We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Bio-Rad Logo


For over six decades, Bio-Rad has served life science research and clinical diagnostics customers worldwide through its global network of operations. Bio-Rad is internationally renowned among academic institutions, pharmaceutical companies and major research institutions for its commitment to quality and customer service.

Latest Bio-Rad Content

Three vials of Starbright dyes.
Product News

Bio-Rad Launches Three StarBright Red Dyes and Expands Range of Antibody Markers Conjugated to StarBright Violet

Bio-Rad’s range of Starbright dyes conjugated to highly validated antibodies now totals 32 dyes, providing greater choice and flexibility for conventional and full-spectrum flow cytometry in immunology research.
Gloved hand holding a 96 well plate in front of a screen displaying qPCR amplification curves.

qPCR vs dPCR: Choosing the Right PCR Technology To Suit Your Experimental Needs

How can you identify which technique is best suited to your research requirements? In this article, we explore the advantages of qPCR and dPCR, considering specific applications and deliverable metrics to help you choose the right technology to suit your experimental needs.
Cancer Research eBook cover

Cancer Research: Bridging Science and Clinical Practice

Through a selection of expert articles, insightful interviews and striking graphics, this eBook offers readers an overview of advances in cancer research.
Biopharma, Biotechnology, Cancer Genetics, Gene Therapy, Genomics Research, PCR, RT-PCR, Real Time PCR

CFX Opus Real-Time PCR Systems from Bio-Rad

The Next Evolution in qPCR: The CFX Opus delivers sensitive, reliable detection of both singleplex and multiplex real-time PCR reactions.
The Landscape of Cancer Research: Advances in Immuno-oncology
Online Event

The Landscape of Cancer Research: Advances in Immuno-oncology 2024

Key advances will be highlighted across the field of immuno-oncology. Hear a cross-section of experts discuss their research with a focus on basic research and a broad range of established and novel immunotherapeutics.
a Scientist holding a vial.
Product News

Bio-Rad Announces Collaboration Agreement With Oncocyte To Commercialize Transplant Monitoring With Droplet Digital PCR

Collaboration aims to provide researchers cutting-edge tools to enable transformational monitoring of key biomarkers in solid tissue transplants.
Someone loading a PCR.
Product News

Bio-Rad and Allegheny Health Network Cancer Institute collaborate to advance personalized monitoring of solid tumor cancers with droplet digital PCR

Collaboration aims to grow clinical evidence supporting the use of bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.
Cancer cells.
Product News

Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection

Highly sensitive and multiplexed assay for the detection, discrimination, and quantification of key mutations in ESR1 gene for breast cancer, developed for bio-Rad’s QX600™ droplet digital™ PCR system.
A PCR Machine.
Product News

Bio-Rad Launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for Cell and Gene Therapy Production

Rapid, sensitive, and validated detection of viral replication genes using droplet digital™ PCR during cell and gene therapy production.
Cell to Cell

Understanding Cell-to-Cell Communication in Cancer

Cell-to-cell communication in cancer is pivotal for tumor progression, metastasis, and treatment resistance. This complex network of signalling pathways allows cancer cells to interact, shaping their behavior and response to therapy.